Suppr超能文献

具有革兰氏阳性抗菌活性的新型细菌双组分系统抑制剂:基于筛选命中药物氯氰碘柳胺的药效团识别

Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel.

作者信息

Hlasta D J, Demers J P, Foleno B D, Fraga-Spano S A, Guan J, Hilliard J J, Macielag M J, Ohemeng K A, Sheppard C M, Sui Z, Webb G C, Weidner-Wells M A, Werblood H, Barrett J F

机构信息

R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ 08869, USA.

出版信息

Bioorg Med Chem Lett. 1998 Jul 21;8(14):1923-8. doi: 10.1016/s0960-894x(98)00326-6.

Abstract

This SAR study has shown that the salicylanilide is the pharmacophore for inhibition of the bacterial two-component system. Hydrophobic substituents improve the potency of inhibitors in this series; however, hydrophobicity is not the sole determinant for inhibition; structural and electronic requirements also exist. Closantel (1) was found to inhibit a two-component system and to have antibacterial activity against drug resistant S. aureus and E. faecium.

摘要

该构效关系研究表明,水杨酰苯胺是抑制细菌双组分系统的药效基团。疏水取代基可提高该系列抑制剂的效力;然而,疏水性并非抑制作用的唯一决定因素;还存在结构和电子方面的要求。已发现氯氰碘柳胺(1)可抑制双组分系统,并对耐甲氧西林金黄色葡萄球菌和粪肠球菌具有抗菌活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验